MindMed to Present at Upcoming May Medical Conferences
MindMed to Present at Upcoming April Medical Conferences
MindMed Announces Voluntary Delisting from Cboe Canada
MindMed to Participate in the Leerink Partners 2024 Global Biopharma Conference
MindMed Receives FDA Breakthrough Therapy Designation From Phase 2B of MM120
MindMed Announces Pricing of Underwritten Offering of Common Shares
MindMed to Host Conference Call and Webcast to Discuss Data Update for MM120
MindMed Reports 2023 Financial Results and Business Updates
MindMed to Host Conference Call and Webcast to Discuss 2023 Financial Results
MindMed to Participate in the 34th Annual Oppenheimer Conference